260 related articles for article (PubMed ID: 23896958)
1. The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease.
Lopez OL; Becker JT; Chang YF; Sweet RA; Aizenstein H; Snitz B; Saxton J; McDade E; Kamboh MI; DeKosky ST; Reynolds CF; Klunk WE
Am J Psychiatry; 2013 Sep; 170(9):1051-8. PubMed ID: 23896958
[TBL] [Abstract][Full Text] [Related]
2. Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease.
Lopez OL; Wisniewski SR; Becker JT; Boller F; DeKosky ST
Arch Neurol; 1999 Oct; 56(10):1266-72. PubMed ID: 10520944
[TBL] [Abstract][Full Text] [Related]
3. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
4. A markov model of the cost effectiveness of olanzapine treatment for agitation and psychosis in Alzheimer's disease.
Kirbach S; Simpson K; Nietert PJ; Mintzer J
Clin Drug Investig; 2008; 28(5):291-303. PubMed ID: 18407715
[TBL] [Abstract][Full Text] [Related]
5. Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial.
Sultzer DL; Davis SM; Tariot PN; Dagerman KS; Lebowitz BD; Lyketsos CG; Rosenheck RA; Hsiao JK; Lieberman JA; Schneider LS;
Am J Psychiatry; 2008 Jul; 165(7):844-54. PubMed ID: 18519523
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.
Mühlbauer V; Möhler R; Dichter MN; Zuidema SU; Köpke S; Luijendijk HJ
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013304. PubMed ID: 34918337
[TBL] [Abstract][Full Text] [Related]
7. Challenges in estimating mortality risk from antipsychotics in people with Alzheimer's disease.
Carnahan RM
Am J Psychiatry; 2014 Feb; 171(2):227. PubMed ID: 24500460
[No Abstract] [Full Text] [Related]
8. All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study.
Liperoti R; Onder G; Landi F; Lapane KL; Mor V; Bernabei R; Gambassi G
J Clin Psychiatry; 2009 Oct; 70(10):1340-7. PubMed ID: 19906339
[TBL] [Abstract][Full Text] [Related]
9. Predictors of nursing home admission among Alzheimer's disease patients with psychosis and/or agitation.
Miller EA; Schneider LS; Rosenheck RA
Int Psychogeriatr; 2011 Feb; 23(1):44-53. PubMed ID: 20214847
[TBL] [Abstract][Full Text] [Related]
10. Assessment of antipsychotic prescribing in Belgian nursing homes.
Azermai M; Elseviers M; Petrovic M; van Bortel L; Stichele RV
Int Psychogeriatr; 2011 Oct; 23(8):1240-8. PubMed ID: 21418723
[TBL] [Abstract][Full Text] [Related]
11. Psychosis, agitation, and antipsychotic treatment in dementia.
Devanand DP
Am J Psychiatry; 2013 Sep; 170(9):957-60. PubMed ID: 24030608
[No Abstract] [Full Text] [Related]
12. Antipsychotic treatment of psychosis and agitation in the elderly.
Daniel DG
J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
[TBL] [Abstract][Full Text] [Related]
13. Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study.
Raivio MM; Laurila JV; Strandberg TE; Tilvis RS; Pitkälä KH
Am J Geriatr Psychiatry; 2007 May; 15(5):416-24. PubMed ID: 17463191
[TBL] [Abstract][Full Text] [Related]
14. Psychosis of Alzheimer's disease: clinical characteristics and history.
Schneider LS; Dagerman KS
J Psychiatr Res; 2004 Jan; 38(1):105-11. PubMed ID: 14690773
[TBL] [Abstract][Full Text] [Related]
15. The use of atypical antipsychotics in nursing homes.
Liperoti R; Mor V; Lapane KL; Pedone C; Gambassi G; Bernabei R
J Clin Psychiatry; 2003 Sep; 64(9):1106-12. PubMed ID: 14628988
[TBL] [Abstract][Full Text] [Related]
16. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
Ballard C; Waite J
Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
[TBL] [Abstract][Full Text] [Related]
18. Risk of pneumonia in elderly nursing home residents using typical versus atypical antipsychotics.
Aparasu RR; Chatterjee S; Chen H
Ann Pharmacother; 2013 Apr; 47(4):464-74. PubMed ID: 23548651
[TBL] [Abstract][Full Text] [Related]
19. Risk of death in dual-eligible nursing home residents using typical or atypical antipsychotic agents.
Aparasu RR; Chatterjee S; Mehta S; Chen H
Med Care; 2012 Nov; 50(11):961-9. PubMed ID: 23047786
[TBL] [Abstract][Full Text] [Related]
20. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
